Author: novacyt

RÉSULTATS ANNUELS 2017 DE NOVACYT Croissance record de 35% du chiffre d’affaires Réduction significative des pertes opérationnelles Perspectives positives pour 2018  

Novacyt FY17 financial results Record revenue growth of 35% Significantly narrowed losses Positive outlook for 2018

Further validation of Novacyt’s expertise in developing assays for clinical applications Novacyt Signs Assay Development Contract for Diagnosis of Respiratory Infections with GenePOC Paris, France and Camberley, UK – 22 March 2018 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its molecular testing division, Primerdesign, has entered into